title: Complications in the treatment of intracranial aneurysms with silk stents: an analysis of 30 consecutive patients.
abstract: Flow-diverting stents (Silk and PED) have radically changed the approach to intracranial aneurysm treatment from the use of endosaccular materials to use of an extraaneurysmal endoluminal device. However, much debate surrounds the most appropriate indications for the use of FD stents and the problems raised by several possible complications.We analysed our technical difficulties and the early (less than ten days after treatment) and late complications encountered in 30 aneurysms treated comprising 13 giant lesions, 12 large, five with maximum diameters <10 mm and one blister-like aneurysm. In our experience the primary indications for the use of FD stents can be the symptomatic intracavernous giant aneurysms. Although the extracavernous carotid siphon aneurysms have major risk of bleeding, FD stents are indicated clearly explaining the risks to the patient in case of severe mass effect. There is a very complex assessment for aneurysms of the vertebrobasilar circulation.
authors.affiliation: Neuroradiology Department, IRCCS of Neurological Sciences, Bellaria Hospital, University of Bologna, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Cirillo
authors.forename: M
authors.initials: M
authors.lastname: Leonardi
authors.forename: M
authors.initials: M
authors.lastname: Dall'olio
authors.forename: C
authors.initials: C
authors.lastname: Princiotta
authors.forename: A
authors.initials: A
authors.lastname: Stafa
authors.forename: L
authors.initials: L
authors.lastname: Simonetti
authors.forename: F
authors.initials: F
authors.lastname: Toni
authors.forename: R
authors.initials: R
authors.lastname: Agati
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002533:Cerebral Angiography; D057510:Endovascular Procedures / Q000009:adverse effects* / Q000295:instrumentation; D005260:Female; D006801:Humans; D002532:Intracranial Aneurysm / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy*; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D047011:Silk / Q000009:adverse effects*; D015607:Stents / Q000009:adverse effects*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D047011:Silk